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Minimallyinvasiveparathyroidectomy(MIP)isanoperativeapproachforthetreatmentofprimaryhyperparathyroidism(pHPT).
Currently, routine use of improved preoperative localization studies, cervical block anesthesia in the conscious patient, and
intraoperative parathyroid hormone analyses aid in guiding surgical therapy. MIP requires less surgical dissection causing
decreased trauma to tissues, can be performed safely in the ambulatory setting, and is at least as eﬀective as standard cervical
exploration. This paper reviews advances in preoperative localization, anesthetic techniques, and intraoperative management of
patients undergoing MIP for the treatment of pHPT.
1.Introduction
Primary hyperparathyroidism (pHPT) is a common end-
ocrine disease caused by a single parathyroid adenoma
in 85% of patients. Identiﬁcation and resection of the
adenoma leads to cure of the disease. Focused unilateral
exploration, that is, minimally invasive parathyroidectomy
(MIP) of enlarged hyperfunctioning gland(s) under regional
anesthetic techniques, has been advocated for the past three
decades [1]. Minimally invasive surgery has been deﬁned
as the ability of the surgeon to preform traditional surgical
procedures employing novel techniques to minimize surgical
trauma[2].Inrecentyears,anumberofnewminimallyinva-
sive techniques have been developed including open mini-
mally invasive parathyroidectomy (MIP) which we describe
in this paper. Other minimally invasive approaches, which
we will not describe, include video-guided, radio-guided,
and endoscopic parathyroidectomies. Prior to current pre-
operative localization studies, unilateral surgery for pHPT
was preformed based upon results of palpation, esophageal
imaging, venography, or arteriography [3, 4]. Unilateral
focusedcervicalexplorationwasalsoadvocatedtoreducethe
cost and morbidity of surgery while maintaining cure rates
[5]. Due to limited exposure obtained during MIP, operative
adjuncts are required to conﬁrm the adequacy of resection.
The intraoperative parathyroid hormone (IOPTH) assay is
now recognized by some experts as the single most useful
adjunct in this setting [6]. Current imaging technology has
enabled preoperative localization of the hyperfunctioning
gland, thus allowing an increasing number of focused uni-
lateral exploration. Sestamibi with single-photon emission
computedtomography(SPECT),ultrasonography,andmore
recently high-quality four-dimensional CT (4DCT) scans
identify hyperfunctioning glands in the majority of patients.
MIPisnowroutinelyperformedathigh-volumecenterswith
excellent cure rates and minimal morbidity.
A large number of studies have been published over
the last decade describing various techniques in minimally
invasive parathyroidectomies, and comparing outcomes to
each other and to that of conventional bilateral exploration.
Table 1 summarizes these studies.
The indications for MIP are identical to those for
traditional bilateral neck exploration, including patients
with symptomatic disease and those with asymptomatic
pHPT in accordance with recently published guidelines [7].
In addition to those patients with overt symptoms and
signs, there is a large number of patients with signiﬁcant
neurocognitive derangements with biochemically proven
pHPT that could potentially beneﬁt from resection [8–10].
The current role of MIP in patients with documented
or suspected familial pHPT is controversial. In the majority
of these patients, conventional bilateral exploration is rec-
ommended due to the frequency of multiglandular disease
[11].2 International Journal of Endocrinology
Table 1: Summary of studies describing technique and outcomes of minimally invasive parathyroidectomy.
Study Methods Study type Success rate Pre-op Intra-op
Adil et al. [46] 305 patients
(1997–2007)
Retrospective case
series 100% success Pre-op sestamibi IOPTH gamma
probe
Krausz et al. [47] 541 patients Prospective cohort
study 97% success Pre-op sestamibi scan or
ultrasound IOPTH
Sevinc ¸e ta l .[ 48] 56 patients (25 MIP, 31
MIRP) Prospective study Similar outcomes Pre-op sestamibi
IOPTH in MIP
gamma probe in
MIRP
Sugino et al. [49]
167 patients (80 IOPTH
monitoring, 87 without
IOPTH monitoring)
Prospective study 97% versus 93% Pre-op sestamibi scan,
ultrasound, or CT scan
Fouquet et al. [50] 200 patients Prospective study 72% success 28%
converted to open
Pre-op sestamibi scan or
ultrasound IOPTH
Hessman et al. [51] 143 patients (75 MIP, 68
VAP)
Multicenter
prospective
randomized control
trial
Similar outcomes
(conversion rate,
pain), VAP longer
Pre-op sestamibi scan IOPTH
Slepavicius et al. [52] 48 patients (24-focused
exploration)
Prospective
randomized control
trial
Similar outcomes Pre-op sestamibi scan or
ultrasound IOPTH
Shindo et al. [53] 186 patients Prospective study
(historical cohort) 95% success Pre-op sestamibi scan or
ultrasound IOPTH
Shindo and Rosenthal
[54] 88 patients Retrospective review 91% success Pre-op sestamibi scan or
ultrasound IOPTH
Rubello et al. [55] 452 patients 344 MIRP Prospective study 93% success Pre-op sestamibi scan or
ultrasound
IOPTH gamma
probe
Lindekleiv et al. [56] 47 patients Retrospective study 97% success Pre-op sestamibi scan IOPTH
Aarum et al. [57] 50 patients 23 MIP, 26
conventional
Prospective
randomized control
trial
96% versus 94% Pre-op sestamibi and
ultrasound IOPTH
Tang et al. [58] 202 patients 50 MIP, 152
open Retrospective study Improved quality of
life
Politz et al. [59] 152 patients (118 MIP,
34 open) Retrospective study 98% success Pre-op sestamibi scan Intra-op gamma
probe
Pang et al. [60] 500 patients prospective Prospective study 97.4% success
Pre-op sestamibi scan +
ultrasound for incision
placement
Soon et al. [61] 699 patients Retrospective study
IOPTH (not
used as
management
aid)
Mihai et al. [62] 298 patients
182-sestamibi 150-MIP Prospective study 97.3% success Pre-op sestamibi scan
Caudle et al. [63] 140 patients Prospective study 96% success Pre-op sestamibi
Intra-op gamma
probe, frozen
section
Alfadda et al. [64] 55 patients Retrospective study 93% success
Carling et al. [43] 441 patients Prospective case
series
10% conversion to
GA (thyroid explo-
ration/conversion to
open
exploration/patient
discomfort)
Pre-op sestamibi scan or
ultrasound IOPTH
Barczynski et al. [65] 60 patients 30 MIP,
30 VAP
Prospective
randomized control
trial
97% success in both
groups, VAP with
decreased pain &
need for analgesia
Pre-op sestamibi and
ultrasound IOPTHInternational Journal of Endocrinology 3
Table 1: Continued.
Study Methods Study type Success rate Pre-op Intra-op
Cohen et al. [66] 130 patients Retrospective review 98.6% success Pre-op sestamibi scan
and/or ultrasound IOPTH
Ollila et al. [67] 77 patients Retrospective review 96% success Pre-op sestamibi scan
Intra-op gamma
probe, selective
frozen section
Miccoli et al. [68] 51 patients 26-RA,
25-GA
Prospective
randomized control
trial
Decreased operative
time and post-op
need for analgesia
with RA
Pre-op sestamibi scan
and ultrasound IOPTH
Mekel et al. [69] 146 patients 84 MIP
(79%) Prospective study Pre-op sestamibi scan or
ultrasound IOPTH
Grant et al. [70] 1361 patients Retrospective review
54% open exploration
44% MIP (2%
conversion)
Rubello et al. [71] 268 patients Retrospective review 96.8% success Pre-op sestamibi and/or
ultrasound IOPTH
Bergenfelz et al. [72] 50 patients 25-MIVAP,
25-open
Prospective
randomized control
trial
Decreased operating
time with MIP Pre-op sestamibi scan IOPTH
In the rare cases (<1%) of suspicion of parathyroid
carcinoma as the etiology of pHPT, a radical resection (i.e.,
an en bloc resection of the involved hyperfunctioning gland
with concomitant ipsilateral thyroid lobectomy) should be
undertaken during the initial procedure [12].
2.PreoperativeImaging
The development and reﬁnement of parathyroid imaging
has been essential for the development of MIP in the treat-
ment of pHPT. Several noninvasive preoperative localiza-
tion methods are available, including sestamibi-technetium
99m scintigraphy, ultrasonography, computed tomography
(CT), and magnetic resonance imaging (MRI). The most
commonly used modality is sestamibi with SPECT, which
generates three-dimensional images [12–15]. Technetium
99m methoxyisobutylisonitrile(sestamibi)wasinitiallyintro-
duced for cardiac scintigraphy and was incidentally found
to be concentrated in parathyroid adenomas [16]. Sestamibi
is a monovalent lipophilic cation that diﬀuses passively
through cell membranes and accumulates almost exclusively
in mitochondria following negative membrane potentials
[17]. Therefore, high mitochondrial density is associated
with sestamibi uptake by human parathyroid tissue [18,
19]. The sensitivity of sestamibi scans in the literature
is 80% [20, 21]. A major limitation of sestamibi scans
is due to the coexistence of thyroid nodules, especially
H¨ urthle cell neoplasms or other metabolically active tissues
(e.g., lymph nodes and metastatic tumors) that can mimic
parathyroid adenomas thereby causing false-positive results.
Theseconcomitantabnormalitieshavebeenreportedtobeas
high as 40–48% [22]. A few studies which have evaluated this
phenomena saw signiﬁcant drops in sensitivity of sestamibi
scintigraphy when utilized in the presence of a nodular
thyroid gland, 96% versus 81% [23] and 92% versus 53%
[24].
Additionally, the parathyroid tumor cell content may
be related to sestamibi uptake. Parathyroid oxyphil cell
content >20% quadruples the rate of obtaining a positive
sestamibi scan, while small adenomas (<600mg) with low
(<20%) numbers of oxyphil cells are usually associated with
an e g a t i v es c a n[ 25]. Additionally, sestamibi with SPECT
does not provide detailed anatomical depiction and can
only rarely detect double adenomas and multiglandular
hyperplasia [26].
Ultrasound (US) is eﬀective, noninvasive, and inexpen-
sive, but its limitations include both operator dependency
andbeinglimitedtoapplicationintheneckbecauseitcannot
image mediastinal tumors. The normal parathyroid gland is
generally too small to be visualized sonographically, whereas
the parathyroid enlargement seen in pHPT is often identiﬁed
as a homogeneously hypoechoic extrathyroidal ovoid mass.
The accuracy of lateralization and correct quadrant localiza-
tion of parathyroid tumors is highly variable, especially for
ultrasound, due to operatordependence. Similar to sestamibi
with SPECT, the ability of an ultrasound to detect the
parathyroid abnormality is reduced in milder forms of
pHPT (i.e., only mildly elevated PTH and calcium levels)
and in obese patients [27]. Thus, some surgeons suggest
reserving sestamibi with SPECT for patients with negative
US or as an adjunct to patients with concomitant thyroid
disease [28, 29]. Additionally, some studies suggestimproved
sensitivity of parathyroid tumor localization using sestamibi
with SPECT and surgeon-performed US [30].
Four-dimensional CT scan (4DCT) is a promising new
parathyroid imaging technique. 4DCT scan is similar to CT
angiography. The term is derived from three-dimensional
CT scanning with the additional dimension referring to4 International Journal of Endocrinology
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Figure 1: Preoperative imaging in primary hyperparathyroidism.
(a)SestamibiwithSPECTdisplayingfocalretentionintheleftlower
position (arrow) after 30 and 75 minutes washout, respectively. (b)
Corresponding cervical ultrasound from the same patient showing
a large hypoechoic cystic parathyroid adenoma (arrow). The left
thyroid lobe (T), trachea (Tr), and left internal jugular vein (IJ)
are indicated. (c) Four-dimensional parathyroid CT scan depicting
an ectopically positioned left superior paraesophageal parathyroid
adenoma (arrow). IJ: internal jugular vein; T: trachea; E: esophagus;
CCA: common carotid artery.
the changes in perfusion of contrast over time. Exquisitely
detailed multiplanar images are obtained to accentuate the
diﬀerences in the perfusion characteristics of hyperfunction-
ing parathyroid glands (i.e., rapid uptake and washout),
compared with normal parathyroid glands and other struc-
tures in the neck (Figure 1). The images provide both
anatomic and functional information (based on changes in
perfusion) in a single study that the operating surgeon can
easily interpret. To date, parathyroid 4DCT has mainly been
used as an adjunct to other imaging modalities in the reme-
dial setting [31]. In a study by Rodgers et al., 4DCT displayed
improved sensitivity (88%) over sestamibi imaging (65%)
and ultrasonography (57%), when these imaging studies
were used to lateralize hyperfunctioning parathyroid glands
to one side of the neck. Moreover, when used to localize
parathyroid tumors to the correct quadrant of the neck (i.e.,
right inferior, right superior, left inferior, or left superior),
the sensitivity of 4D-CT (70%) was signiﬁcantly higher than
sestamibi imaging (33%) and ultrasonography (29%) [31].
Even in patients with negative, discordant, or uncon-
vincing preoperative imaging studies, the cure rates are
excellentinexperiencedhands;however,invasivelocalization
procedures such as selective parathyroid venous sampling
(SVS) with measurements of PTH may be indicated. Rapid
PTH measurements have been successfully employed in
the angiography suite, and interventional radiologists can
obtain additional samples from a region in which a subtle
but potentially signiﬁcant PTH gradient is detected [32].
Ultrasonography can be employed to guide preoperative
aspiration of a putative parathyroid gland in which PTH is
measured to conﬁrm that the suspected tissue is parathyroid.
This technique, like venous localization, should be reserved
for remedial cases [33].
3.Anesthesia
The majority of parathyroid explorations are performed
under general anesthesia utilizing either a standard general
endotracheal tube (ETT) or a laryngeal mask airway (LAM).
Conversely, high-volume centers have utilized monitored
anesthesia care (MAC) with local and regional anesthesia.
The regional block can be performed by the surgeon, just
prior to incision after mild intravenous sedation has been
administered (Figure 2). We use 1% lidocaine containing
1:100000 epinephrine employing a total of 20mL.
Intravascular inﬁltration of local analgesic agents must
be avoided. Unilateral inﬁltration posteriorly at Erb’s point
(located on the posterior border of the sternocleidomastoid
muscle midway between its attachments to the mastoid
process, the sternum, and the clavicle) and along the anterior
border of the sternocleidomastoid muscle on the side of
the localized gland and along the area of incision provides
excellent analgesia during virtually every case. Intravenous
sedation is maintained to alleviate patient anxiety while
maintaining a patient who is capable of phonating.
Regionalanesthesiafortheresectionofhyperfunctioning
parathyroid glands avoids potential complications associated
with general anesthesia, which includes endotracheal intuba-
tion, which has been associated with up to a 5% risk of vocal
cord changes and damage [35]. Furthermore, with patients
remaining conscious during exploration, the operating sur-
geon may assess functional status of phonation. Conversion
to general anesthesia is occasionally performed and may
be due to concomitant thyroid pathology, concern for
parathyroid carcinoma, persistently elevated intraoperative
PTH levels, diﬃculty in ensuring the safety of the recurrent
laryngeal nerve, and patient discomfort [3]. Regardless of
the reason for conversion in all cases, conversion should beInternational Journal of Endocrinology 5
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Figure 2: Cervical block anesthesia. (a) A superﬁcial cervical block is administered posterior and deep to the sternocleidomastoid muscle
(SCM; 1). (b) Local inﬁltration is also performed along the anterior border of the SCM [2], followed by a local ﬁeld block [3]. (From [34],
with permission, Copyright 2002, Lippincott Williams &Wilkins).
done in a controlled fashion with protection of the surgical
ﬁeld [3]. We recently reported a 10.6% conversion to general
anesthesia in a study of 441 consecutive patients [25].
4. Procedure
A 20-gauge intravenous catheter is placed in the antecubital
fossa, and a single baseline PTH level is obtained in the
preoperative holding area. The patient is transported to
the operating room and placed in the semifowler position,
and a screen is used to protect the patient’s face from the
operative ﬁeld. The anesthesia personal will require access to
the intravenous line to obtain PTH measurements (Figure 3)
[34]. Moderate sedation is administered, and a regional
cervical nerve block is then administered as described. An
abbreviated Kocher incision (approximately 3cm) is then
made, and the anterior compartment of the neck entered
the median raphe is mobilized, the parathyroid adenoma
visualized, the recurrent laryngeal nerve is protected, and the
adenoma is excised.
Once resection is complete, serial blood draws are
obtained. Adequacy of resection is conﬁrmed when the
patient’s preoperative baseline PTH level decreases by at least
50% and returns to the normal range [36–40].
5.IntraoperativeParathyroid
Hormone Monitoring
In 1990, intraoperative PTH monitoring was introduced
and allowed for a biochemical alternative to direct four-
gland visualization [41]. Prior to this, multiglandular disease
Fan
Air directed to
patient’s face
to minimize
claustrophobia
Site of
intraoperative
sampling of
parathyroid
hormone
Figure 3: The patient has a large-bore peripheral intravenous line
inserted, which is used for medication and ﬂuid administration, as
wellassamplingforparathyroidhormone(PTH)levels.Thepatient
is awake, and a fan is used to blow room air gently toward his or her
face to minimize the sensation of claustrophobia. (From [36], with
permission, Copyright 2002, Lippincott Williams & Wilkins).
could not be accurately ruled out without directly visualizing
at least all four glands. Intraoperative PTH monitoring is
feasible because PTH has a short half-life of the hormone
(3–5minutes). In some patients, the PTH level fails to
decline after resection, thus indicating residual abnormal
parathyroid tissue, and further exploration is required.6 International Journal of Endocrinology
Since the most advantageous time to cure pHPT is during
the ﬁrst surgical exploration, it is the obligation of the
surgeon to perform a meticulous exploration, evaluating
both eutopic and ectopic sites. This exploration may include
the retroesophageal space, thymus gland, carotid sheaths,
and submandibular region for undescended glands. If the
occult gland is still not identiﬁed, additional intraoperative
adjuncts may be used, including ultrasound and bilateral
internal jugular vein sampling to determine if an ipsilateral
PTH gradient is present. This technique has guided us to
explore upstream and locate occult undescended or partially
descended glands. Partial or complete thyroid lobectomy
for intrathyroidal parathyroid tumors can be performed
depending on the suspected location of the missing gland.
In the case of diﬃcult localization of the hyperfunctioning
gland, a traditional bilateral exploration may need to be
performed. In the rare case where a mediastinal gland is
suspected after bilateral exploration has not revealed the
hyperfunctioning gland, a partial sternotomy may rarely be
required during initial exploration [42].
6. Complications
The complications that may be associated with MIP are
the same as complications that may be associated with
conventional bilateral exploration, and the complication
rates are at least as low as those associated with the latter.
However, due to the use of regional anesthesia, MIP avoids
potential complications associated with general anesthesia,
which includes endotracheal intubation, which has been
associated with the risk of vocal cord changes and damage.
Hematomas and ipsilateral recurrent laryngeal nerve injury
may occur with MIP. Temporary hypocalcemia (due to
hungry bone syndrome) may also occur. In a prospectively
collected and retrospectively reviewed series of 656 consecu-
tive parathyroidectomies performed between 1990 and 2001
(of which 401 were performed in the conventional fashion,
and 255 were performed as MIP), we reported no signiﬁcant
diﬀerence in complication rates (3% and 1.2%, resp.) or cure
rates (97% and 99%, resp.) [43].
7. Patients with Recurrentor
PersistentDisease
Despite modern preoperative imaging techniques, endocrine
surgeons are still faced with three distinct groups of patients
who present unique and challenging management issues: (1)
those with persistent pHPT, (2) or recurrent, and lastly (3)
those who have had prior neck surgery, particularly thyroid
resections, and develop pHPT. Other situations of diﬃcult
neckdissectionsariseinthesettingofparathyroidcarcinoma
and parathyromatosis due either to carcinoma or spillage
during a previous adenoma resection and those patients
who have had radiation to the neck and/or mediastinum.
Regardless of the pathophysiology, the challenge is the same
as remedial surgery in previously violated surgical planes.
Reoperative cervical and mediastinal exploration is associ-
atedwithanoverallincreaseoffailureandcomplicationrates
[44, 45].
8. Conclusions
Due to the signiﬁcant advancements in technology, MIP
has become the procedure of choice for sporadic pHPT at
specialized centers. Minimally invasive parathyroidectomy
has improved cosmetic results due to smaller incisions,
decreased surgical trauma leading to less postoperative pain,
shorter operative times, and a decreased overall hospital stay.
The rate of cure was recently shown to be comparable or
improvedcomparedtotraditionalbilateralneckexplorations
and can be performed in the outpatient setting. It is to be
emphasized that MIP and conventional cervical exploration
are both highly successful and associated with low compli-
cation rates. Surgeon experience, regardless of the technique
employed, is paramount to obtain excellent results.
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